Veradermics Inc.
PublicVeradermics Inc. is now publicly traded
The data on this page reflects Veradermics Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Feb 3, 2026
Last Round
Follow-on Offering
May 15, 2026
Total Funding Raised
$570.5M
Company Overview
Veradermics Inc. is a biopharmaceutical company that develops first-in-class therapeutics for dermatologic and aesthetic conditions, including pattern hair loss, common warts, and molluscum contagiosum.
AI Layer
Non-AI
Keywords
Veradermics Inc. Comparables
Compare Veradermics Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for Veradermics Inc.. Request access to learn about comparables coverage.
Request accessVeradermics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | May 15, 2026 | ||||
| IPO | Feb 3, 2026 | ||||
| Series C | Oct 16, 2025 | ||||
| Series B | Dec 11, 2024 | ||||
| Series A | Sep 22, 2021 |
Key People
Founding team and executive leadership
Veradermics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| Longitude Capital | Series B, Series C |
| Surveyor Capital | Series C |
| Connecticut Innovations | Series B, Series A |
| LifeSci Venture Partners | Series C |
| abrdn Inc. | Series C |
| Columbia Threadneedle Investments | Series C |
Recent news
Latest coverage and updates
- receives_financingAug 12, 2026
Veradermics, Inc. received financing of $472M on Jul 6th '26.
- is_developingAug 12, 2026
Veradermics, Inc. is developing treatment for both men and women with pattern hair loss on Aug 12th '26.
Veradermics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access